Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cristy K. Hanover"'
Autor:
Paula K. Locker, Gary Elfring, Mark A. Socinski, Alan B. Sandler, Langdon L. Miller, Nicoletta Pirotta, Ronald B. Natale, Cristy K. Hanover, Valerie Israel
Publikováno v:
Clinical lung cancer. 2
The objectives of this phase I/II trial were to determine the maximum tolerated dose, toxicities, and the dose suitable for phase II/III trials of irinotecan (CPT-11) combined with paclitaxel and carboplatin in patients with advanced non–small-cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b243b3435012bbb63983485dc679e01
https://pubmed.ncbi.nlm.nih.gov/14725727
https://pubmed.ncbi.nlm.nih.gov/14725727
Autor:
Paula K. Locker, Cristy K. Hanover, Valerie Israel, Nicoletta Pirotta, Ronald B. Natale, Mark A. Socinski, Alan B. Sandler, Langdon L. Miller, Gary Elfring
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(4)
PURPOSE: To determine the maximum-tolerated dose, toxicities, and dose suitable for phase II/III trials of irinotecan (CPT-11) combined with paclitaxel and carboplatin in patients with advanced non–small-cell lung cancer (NSCLC). PATIENTS AND METHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b1c74d5f974ea65197b75d831485f2
https://pubmed.ncbi.nlm.nih.gov/11181672
https://pubmed.ncbi.nlm.nih.gov/11181672
Autor:
J Kanowitz, Nancy E. Kemeny, David H. Ilson, Deborah Semple, Larry J. Schaaf, Leonard B. Saltz, Langdon L. Miller, Cristy K. Hanover, Gary Elfring, M Eng, P Albanese, David R. Spriggs, David P. Kelsen, Gary K. Schwartz, C Steger
Publikováno v:
Scopus-Elsevier
PURPOSE In vitro synergy between cisplatin and irinotecan (CPT-11) has been reported. We designed a combination schedule of these agents to maximize the potential for synergistic interaction. PATIENTS AND METHODS To maximize the opportunity for syner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85c6d7be35b6355dc76a60c3a72bce43
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032407409&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032407409&partnerID=MN8TOARS
